Berkeley Lights Archives | Be Korea-savvy

Home / Posts tagged Berkeley Lights

Berkeley Lights and Bayer Announce a Multi-year Agreement Aimed at Revolutionizing the Discovery of Next-generation Traits

EMERYVILLE, Calif., Aug. 11 (Korea Bizwire) — Berkeley Lights, Inc. (Nasdaq: BLI) a leader in the functional characterization of live biology, announced a multi-year agreement with Bayer to develop and perform high-throughput functional screening workflows aimed at accelerating and expanding the discovery of novel traits. Terms of the agreement were not disclosed. Berkeley Lights will leverage its [...]

Berkeley Lights Announces Opto™ Assure for Early Manufacturability Assessment of Antibody Therapeutics

EMERYVILLE, Calif., April 5,(Korea Bizwire) — Today, Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, announced the launch of Opto Assure, a series of assays that provides yield and product quality data at an earlier stage in cell line development. The first of the series enables direct detection of product aggregates, ensuring [...]

Berkeley Lights Launches Opto Plasma B Discovery 4.0 to Accelerate Therapeutic Antibody Discovery Against Difficult Targets

EMERYVILLE, Calif., Jan. 12 (Korea Bizwire) — Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the Opto™ Plasma B Discovery 4.0 workflow. Opto Plasma B Discovery 4.0 is the industry’s premier antibody discovery workflow by advancing from B cells to lead molecules in just 1 week. This workflow enables our [...]

Berkeley Lights Makes Debut in Taiwan as Mycenax Acquires the BeaconⓇ Optofluidic System for Cell Line Development

MIAOLI, Taiwan and EMERYVILLE, Calif., Sept. 9 (Korea Bizwire) — Mycenax Biotech, Inc. (4726.TWO), a pioneer of biopharmaceutical development in Taiwan, today announced its adoption of the Berkeley Lights Platform for cell line development. Berkeley Lights, Inc., (Nasdaq: BLI), a leader in Digital Cell Biology, continues to see adoption of the system in Asia Pacific, [...]